How has been the historical performance of Nephro Care?
2025-11-13 00:41:55Answer: The historical performance of Nephro Care shows significant growth over the years, particularly from March 2022 to March 2025. Breakdown: Nephro Care's net sales have increased dramatically from 3.42 Cr in March 2022 to 46.03 Cr in March 2025, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 3.42 Cr in March 2022 to 46.03 Cr in March 2025. The company's total expenditure also grew, reaching 40.16 Cr in March 2025 from just 3.30 Cr in March 2022. Operating profit, excluding other income, peaked at 5.87 Cr in March 2025, although it was slightly lower than the previous year's 6.47 Cr. Profit before tax showed fluctuations, with a high of 6.22 Cr in March 2024 but dropping to 4.83 Cr in March 2025. Profit after tax reached 3.64 Cr in March 2025, down from 4.50 Cr in March 2024, yet still a significant improvement from the loss of 0.01 Cr in March 2022...
Read MoreWhy is Nephro Care falling/rising?
2025-11-08 00:40:37As of 07-Nov, Nephro Care India Ltd is experiencing a decline in its stock price, currently at 128.00, which reflects a decrease of 0.55 or 0.43%. The stock has been trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the stock has shown a significant drop in performance over various periods, with a 1-week decline of 6.09% and a year-to-date decrease of 30.43%. However, there has been a notable increase in investor participation, with delivery volume rising by 85.67% against the 5-day average, suggesting some interest despite the overall downward movement. Unfortunately, there is no information available regarding positive or negative factors that could further clarify the stock's recent performance. In the broader market context, Nephro Care's short-term performance has been considerably worse than the benchmark, with the Sensex onl...
Read MoreWhy is Nephro Care falling/rising?
2025-11-03 23:57:19As of 03-Nov, Nephro Care India Ltd is currently priced at 134.90, reflecting a decrease of 1.4, or 1.03%. The stock has underperformed its sector today by 2.41%. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past week, the stock has declined by 2.39%, and it has experienced significant losses year-to-date, down 26.68%, and over the past year, down 47.43%. There is a notable increase in investor participation, with delivery volume rising by 169.63% against the 5-day average, suggesting some interest despite the overall negative performance. However, there are no positive or negative factors provided that could further clarify the reasons behind the stock's recent movement. In the broader market context, Nephro Care's short-term performance has been significantly worse than the benchmark, with the Sensex only declining...
Read MoreWhy is Nephro Care falling/rising?
2025-09-24 23:51:48As of 24-Sep, Nephro Care India Ltd is currently priced at 142.65, reflecting a slight increase of 0.5 (0.35%). The stock has shown a performance today that outperformed its sector by 0.97%. However, it has experienced a significant decline over the past month, down 18.06%, and a year-to-date drop of 22.47%. Additionally, the stock's delivery volume has decreased by 54.82% compared to the 5-day average, indicating falling investor participation. The stock is currently trading above its 100-day moving average but below its 5-day, 20-day, 50-day, and 200-day moving averages, suggesting mixed signals regarding its recent price movement. There are no positive or negative factors available to further explain the stock's recent performance. In the broader market context, Nephro Care's short-term return of -6.00% over the past week contrasts sharply with the Sensex, which has only declined by 1.08% during the sam...
Read MoreWhy is Nephro Care falling/rising?
2025-09-24 00:00:57As of 23-Sep, Nephro Care India Ltd's stock price is currently at 142.15, reflecting a decrease of 1.1, or 0.77%. The stock has underperformed its sector by 0.3% today and has shown a significant decline in performance over various periods, with a 1-week return of -7.03% and a year-to-date return of -22.74%. Additionally, the stock's delivery volume has decreased by 45.71% compared to the 5-day average, indicating falling investor participation. The stock is currently trading higher than its 100-day moving average but lower than its 5-day, 20-day, 50-day, and 200-day moving averages, suggesting mixed signals regarding its recent momentum. There is no information available regarding positive or negative factors that could further explain the stock's movement. Broader market context shows that while Nephro Care's stock has declined significantly, the benchmark Sensex has only fallen by 2.97% over the past ye...
Read MoreWhy is Nephro Care falling/rising?
2025-09-22 23:51:08As of 22-Sep, Nephro Care India Ltd is experiencing a decline in its stock price, currently at 143.25, reflecting a decrease of 3.8 points or 2.58%. The stock has underperformed its sector by 2.15% today, and its delivery volume has significantly decreased by 47.98% compared to the 5-day average, indicating falling investor participation. Additionally, while the stock is above its 100-day moving average, it remains below the 5-day, 20-day, 50-day, and 200-day moving averages, suggesting a bearish trend. Over the past week, the stock has dropped by 9.74%, and it has seen a substantial decline of 22.15% year-to-date, which further highlights its poor performance relative to the market. In the broader market context, the Sensex has shown a positive return of 0.53% over the past week, contrasting sharply with Nephro Care's significant decline. This underperformance is evident as the stock has fallen 17.72% ove...
Read MoreWhy is Nephro Care falling/rising?
2025-09-19 23:47:30As of 19-Sep, Nephro Care India Ltd's stock price is currently at 147.05, reflecting a decrease of 1.35, or 0.91%. The stock has underperformed its sector by 0.72% today, and while it is trading higher than the 50-day and 100-day moving averages, it is below the 5-day, 20-day, and 200-day moving averages. Over the past week, the stock has seen a significant decline of 10.34%, contrasting with a modest gain of 0.85% in the Sensex. Year-to-date, the stock is down 20.08%, while the Sensex has increased by 7.11%. Notably, there has been a rise in investor participation, with a delivery volume of 19.6k on September 18, which is up 64.43% compared to the 5-day average, indicating increased trading interest despite the stock's decline. In the broader market context, Nephro Care's recent performance has been notably weaker than the benchmark, particularly in the short term, where it has underperformed significantl...
Read MoreWhy is Nephro Care falling/rising?
2025-09-18 23:50:10As of 18-September, Nephro Care India Ltd is experiencing a decline in its stock price, currently at 148.40, which reflects a decrease of 3.35 or 2.21%. The stock has underperformed its sector today by 2.1%. In terms of returns, over the past week, the stock has decreased by 9.43%, while it has shown a modest increase of 6.76% over the past month. However, year-to-date, the stock has fallen by 19.35%, and over the past year, it has seen a significant decline of 43.46%. The stock is currently trading higher than its 50-day and 100-day moving averages but lower than its 5-day, 20-day, and 200-day moving averages. Additionally, there has been a rise in investor participation, with delivery volume increasing by 8.7% compared to the 5-day average, indicating some interest despite the price drop. Unfortunately, there is no information available regarding positive or negative factors impacting the stock. In the b...
Read MoreWhy is Nephro Care falling/rising?
2025-09-17 23:33:48As of 17-Sep, Nephro Care India Ltd's stock price is currently at 151.75, reflecting a decrease of 1.15, or 0.75%. The stock has underperformed its sector by 0.95% today. In terms of recent performance, the stock has shown a significant decline over the past week, down 7.47%, while it has increased by 8.86% over the past month. Year-to-date, the stock is down 17.53%, and over the past year, it has decreased by 42.94%. The moving averages indicate that the stock is higher than the 50-day and 100-day moving averages but lower than the 5-day, 20-day, and 200-day moving averages. Notably, there has been a rise in investor participation, with delivery volume increasing by 87.97% against the 5-day average, suggesting heightened interest despite the stock's recent decline. There are no positive or negative factors available to further explain the stock's movement. Broader market context shows that while Nephro Ca...
Read MoreCorporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






